Synopsis of recent research by authors named "Dalia W Zidan"
Dalia W Zidan's research primarily focuses on the development and validation of novel spectrophotometric and chromatographic methods for the simultaneous determination of antiviral and anticancer drugs related to Hepatitis C virus (HCV) treatment and hepatocellular carcinoma (HCC).
Her studies include innovative approaches such as multivariate calibration-prediction techniques and micellar high-performance liquid chromatography (HPLC), demonstrating the capability to analyze compounds like ribavirin, sofosbuvir, daclatasvir, and sorafenib in complex biological samples like human plasma and urine.
Zidan's findings offer significant advancements in analytical methods that enhance the accuracy and efficiency of drug quantification, which is essential for monitoring pharmacotherapy in patients with HCV and associated conditions.
